Dr. Swindlehurst is a founder and CEO of NovoMedix. She has over 25 years of experience in biotech and has a broad background in assay and biomarker development; drug discovery and development; as well as in project management, business development, and fund raising. Dr. Swindlehurst has held V.P. positions at several companies, including PanCel , MagneSensors, and NovaDx. She has led key collaborations with academic researchers and corporate partners and has been directly involved in raising over $10M in financing. Dr. Swindlehurst is an inventor on NovoMedix’s key issued patents. In her role as CEO of NovoMedix, Dr. Swindlehurst has also raised $5M in non-dilutive funding. Dr. Swindlehurst received a certificate in Business Management from UC San Diego; Ph.D. in Analytical Chemistry and Postdoctoral fellowship in Immunology from University of Illinois, Champaign Urbana; and her B.S. in Chemistry from University of California, Irvine.